JRCT ID: jRCT2080220894
Registered date:19/10/2009
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Ulcerative Colitis |
Date of first enrollment | 19/10/2009 |
Target sample size | |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : AJM300 INN of investigational material : Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investigational material : Oral |
Outcome(s)
Primary Outcome | Mayo score, Safety |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 16age old |
---|---|
Age maximum | <= 64age old |
Gender | Both |
Include criteria | Patients with active-phase ulcerative colitis - The Mayo score of 6 to 10. - Inadequate response to or intolerance of appropriate conventional therapy |
Exclude criteria |
Related Information
Primary Sponsor | Ajinomoto Pharmaceuticals Co., Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-090925 |
Contact
Public contact | |
Name | |
Address | contact_ij@ajinomoto.com |
Telephone | |
Affiliation | Ajinomoto Pharmaceuticals Co., Ltd. |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |